These conditions are characterized by insulin resistance, excess abdominal weight, and elevated blood sugar levelsmechanisms that oral semaglutide directly targets
Induction of mGlu2 receptors is mediated by acetylation mechanisms that involve transcription factors of the nuclear factor (NF)-B family
Tirzepatide was approved in 2022 as Mounjaro for diabetes, and in 2024 as Zepbound for obesity, with exclusivity running until May 2027
So, to be clear, only Wegovy and Zepbound are officially approved for obesity management
Nausea and vomiting rates appeared slightly elevated compared to tirzepatide at equivalent phases of dose escalation
It feels like you have control of your life. Before, Morales was on a constant seesaw of overeating and then starving herself